Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 0.97 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.97 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.74 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Meclofenoxate SCHEMBL28363047 | 0.98 | CYP1A2 (0.97) | CYP1A2CYP3A4CYP2C19BLMPMP22 | |
| Meclofenoxate SCHEMBL218322 | 0.98 | BLM (1.00) | CYP1A2CYP3A4CYP2C19BLMPMP22 | |
| Meclofenoxate SCHEMBL1172142 | 0.97 | CYP1A2 (0.94) | CYP1A2CYP3A4CYP2C19BLMPMP22 | |
| SCHEMBL12742257 | 0.86 | SMN1; SMN2 (0.97) | CYP1A2CYP3A4CYP2C19BLMPMP22 | |
| SCHEMBL31122986 | 0.84 | SMN1; SMN2 (0.73) | CYP1A2CYP3A4CYP2C19BLMPMP22 | |
| SCHEMBL28252143 | 0.83 | CYP1A2 (0.70) | CYP1A2CYP3A4CYP2C19BLMPMP22 | |
| SCHEMBL6598625 | 0.82 | HRH3 (0.69) | CYP1A2CYP3A4CYP2C19BLMPMP22 | |
| SCHEMBL21384542 | 0.81 | CYP1A2 (0.68) | CYP1A2CYP3A4CYP2C19BLMPMP22 | |
| SCHEMBL25391970 | 0.80 | TDP1 (0.70) | CYP1A2CYP3A4CYP2C19BLMPMP22 | |
| SCHEMBL6599620 | 0.80 | HRH3 (0.67) | CYP1A2CYP3A4CYP2C19BLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| US-20250152601-A1 | Compositions and Methods for the Treatment of Sexual Dysfunctions | THE JONATHAN HURT LIVING TRUST (US) | 2025-05-15 | — | — | US | claimed |
| CN-119015253-A | Water-medicine complex and preparation method thereof | 天津医科大学第二医院 | 2024-11-26 | — | — | CN | claimed |
| CN-118355836-A | Planting method for improving rice yield per unit | 长沙市农业技术推广中心(湖南省农业广播电视学校长沙市分校) | 2024-07-19 | — | — | CN | claimed |
| US-20240043473-A1 | NOOTROPIC PEPTIDES FOR TREATING LYSOSOMAL STORAGE DISEASES | PHOENIX NEST INC. | 2024-02-08 | — | — | US | claimed |
| EP-4291237-A1 | NOOTROPIC PEPTIDES FOR TREATING LYSOSOMAL STORAGE DISEASES | Phoenix Nest Inc. (US) | 2023-12-20 | — | — | EP | claimed |
| WO-2023164338-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS | THE JONATHAN HURT LIVING TRUST (US) | 2023-08-31 | — | — | WO | claimed |
| US-20230157976-A1 | HEXYLAMINE SALTS AND METHODS OF USING HEXYLAMINE | THERMOLIFE INTERNATIONAL, LLC | 2023-05-25 | — | — | US | claimed |
| CN-115835862-A | Combination for treating alzheimer's disease and use thereof | 广州新创忆药物临床研究有限公司 | 2023-03-21 | — | — | CN | claimed |
| US-11541020-B2 | Hexylamine salts and methods of using hexylamine | THERMOLIFE INTERNATIONAL, LLC (US) | 2023-01-03 | — | — | US | claimed |
| US-6174890-B1 | A SYNERGISTIC BIOLOGICAL, NEUROMETABOLIC AND CELLTROPHIC COMPOSITION COMPRISING ANTIOXIDATIVE AND -CATABOLIC STRESS (METHIONINE),-ANABOLIC DRUGS, VASODILATIVE AND NORMO-LIPIDEMIC DRUGS (NICOTINIC ACID), ENERGOACTIVE AND ANTITOXIC | RIGA DAN (RO) | 2001-01-16 | — | — | US | claimed |
| EP-1038520-A1 | Cosmetics containing meclofenoxate | Chabrier, Pierre-Marie (FR) | 2000-09-27 | — | — | EP | claimed |
| EP-1005651-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA, INC. (CA) | 2000-06-07 | — | — | EP | claimed |
| EP-0804239-B1 | ANTI-STRESS, ANTI-IMPAIRMENT AND ANTI-AGING DRUG AND PROCESS FOR MANUFACTURING THEREOF | RIGA DAN (RO) | 1999-09-15 | — | — | EP | claimed |
| WO-1999008112-A1 | METHODS OF IDENTIFYING BIOLOGICAL AGENT COMPOSITIONS | SUPRATEK PHARMA INC. (CA) | 1999-02-18 | — | — | WO | claimed |
| EP-0804239-A1 | ANTI-STRESS, ANTI-IMPAIRMENT AND ANTI-AGING DRUG AND PROCESS FOR MANUFACTURING THEREOF | Riga, Dan (RO) | 1997-11-05 | — | — | EP | claimed |
| EP-0580860-B1 | METHOD OF MANUFACTURING SOLID DISPERSION | NIPPON SHINYAKU CO LTD (JP) | 1997-10-22 | — | — | EP | claimed |
| CN-1156410-A | Anti-stress, anti-injury and anti-aging medicine and production method thereof | RIGA D (RO) | 1997-08-06 | — | — | CN | claimed |
| WO-1995033486-A1 | ANTI-STRESS, ANTI-IMPAIRMENT AND ANTI-AGING DRUG AND PROCESS FOR MANUFACTURING THEREOF | RIGA DAN (RO) | 1995-12-14 | — | — | WO | claimed |
| EP-0116238-A1 | Therapeutic compositions and their use in enhancing brain function | BIOMEASURE, INC. (US) | 1984-08-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11541020-B2 | Hexylamine salts and methods of using hexylamine | SLC6A2, CPT1B, GYS1 | CYP1A2 960/4885CYP3A4 801/4885CYP2C19 657/4885 |
| US-20230157976-A1 | HEXYLAMINE SALTS AND METHODS OF USING HEXYLAMINE | SLC6A2, CPT1B, GYS1 | CYP1A2 960/4885CYP3A4 801/4885CYP2C19 657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.